License Agreements in the Pharmaceuticals Industry

1,224 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT between RESPIVERT LTD and PULMATRIX,INC. 1
License Agreements
Pulmatrix, Inc.
Pharmaceuticals
DE
2017
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2024
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2024
First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc
License Agreements
Liquidia Corp
Pharmaceuticals
2024
Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc
License Agreements
Liquidia Corp
Pharmaceuticals
DE
2024
First Amendment to the License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of September 22, 2023
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2024
License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of July 27, 2023
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Rest of World License Term Sheet, dated October 8, 2024, between Oramed Pharmaceuticals Inc., Scilex Holding Company and the other parties signatories thereto
License Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2024
Patent License Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated October 12, 2021
License Agreements
Apimeds Pharmaceuticals US, Inc.
Pharmaceuticals
DE
2024
LICENSE AGREEMENT
License Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2024
Intellectual Property Cross License Agreement, dated as of May 28, 2024, by and between Pulmatrix, Inc. and MannKind Corporation
License Agreements
Pulmatrix, Inc.
Pharmaceuticals
DE
2024
First Amendment to License Agreement, by and among the Registrant and BioCryst Pharmaceuticals, Inc., dated as of May 20, 2024
License Agreements
Clearside Biomedical, Inc.
Pharmaceuticals
2024
Exclusive License Agreement between CNS Pharmaceuticals, Inc. and Cortice Biosciences, Inc
License Agreements
CNS Pharmaceuticals, Inc.
Pharmaceuticals
TX
2024
License Agreement, by and between the Company and Pharma 1 Drug Store, L.L.C
License Agreements
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2024
License and Commercialization Agreement between Nippon Kayaku Co., Ltd. and AnHeart Therapeutics Inc, dated October 27, 2023
License Agreements
Panacea Acquisition Corp
Pharmaceuticals
2024
License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated September 7, 2020
License Agreements
Panacea Acquisition Corp
Pharmaceuticals
NY
2024
First Amendment to License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therpaeutics Inc., dated August 17, 2020
License Agreements
Panacea Acquisition Corp
Pharmaceuticals
2024
License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated December 7, 2018
License Agreements
Panacea Acquisition Corp
Pharmaceuticals
NY
2024
First Amendment to Amended and Restated License Agreement, dated March 16, 2024, by and between Napo Pharmaceuticals, Inc. and Nano Therapeutics S.p.A
License Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
First Amendment to License Agreement, dated
License Agreements
Cerecor Inc.
Pharmaceuticals
2024
License Agreement by, dated November 25, 2019, by and between Flame Biosciences LLC and Eli Lilly and Company
License Agreements
Cerecor Inc.
Pharmaceuticals
NY
2024
Amended and Restated License Agreement, dated January 27, 2012, between the Registrant and Incept LLC
License Agreements
OCULAR THERAPEUTIX, INC
Pharmaceuticals
DE
2024
Amendment No. 2 to License and Commercialization Agreement, dated July 28, 2017, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC
License Agreements
Harmony Biosciences Holdings, Inc.
Pharmaceuticals
2024
Amendment No. 1 to License and Commercialization Agreement, dated July 31, 2022, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC
License Agreements
Harmony Biosciences Holdings, Inc.
Pharmaceuticals
2024
Amended and Restated Intellectual Property License Agreement with Premier Anti-Aging Co., Ltd. dated March 15, 2024
License Agreements
Lexaria Bioscience Corp.
Pharmaceuticals
DE
2024
License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022
License Agreements
Zomedica Pharmaceuticals Corp.
Pharmaceuticals
NY
2024
Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd
License Agreements
OMEROS CORP
Pharmaceuticals
2024
Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd
License Agreements
OMEROS CORP
Pharmaceuticals
2024
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010
License Agreements
OMEROS CORP
Pharmaceuticals
NY
2024
Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between...
License Agreements
SCYNEXIS INC
Pharmaceuticals
2024
Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami
License Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2024
License Agreement Dated June 15, 2023 by and between Star Brands and Medicine Man Technologies, Inc
License Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2024
Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2024
License Agreement, effective as of March20, 2024, by and between cbdMD, Inc. and HSKL, Inc
License Agreements
Level Brands, Inc.
Pharmaceuticals
2024
License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc
License Agreements
Liquidia Corp
Pharmaceuticals
DE
2024
Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024
License Agreements
Clearside Biomedical, Inc.
Pharmaceuticals
GA
2024
License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023
License Agreements
Clearside Biomedical, Inc.
Pharmaceuticals
DE
2024
License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V. and Symatese Aesthetics S.A.S
License Agreements
Evolus, Inc.
Pharmaceuticals
CA
2024
Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant
License Agreements
Evolus, Inc.
Pharmaceuticals
2024
First Amendment to License and Supply Agreement, dated as of February 26, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant
License Agreements
Evolus, Inc.
Pharmaceuticals
2024
License Agreement dated January 12, 2024 by and among Lipocine, Inc., Gordon Silver Limited, and Verity Pharmaceuticals
License Agreements
Lipocine Inc.
Pharmaceuticals
NY
2024